HOOKIPA Pharma Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
HOOKIPA Pharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • HOOKIPA Pharma Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.8M, a 33.3% increase year-over-year.
  • HOOKIPA Pharma Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $17.7M, a 50.5% increase year-over-year.
  • HOOKIPA Pharma Inc. annual Nonoperating Income (Expense) for 2023 was $16.5M, a 94.6% increase from 2022.
  • HOOKIPA Pharma Inc. annual Nonoperating Income (Expense) for 2022 was $8.47M, a 40.9% increase from 2021.
  • HOOKIPA Pharma Inc. annual Nonoperating Income (Expense) for 2021 was $6.01M, a 34.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.5M +$8.01M +94.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $8.47M +$2.46M +40.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $6.01M -$3.19M -34.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-22
2020 $9.2M +$1.16M +14.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $8.05M +$3.08M +62% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-24
2018 $4.97M +$3.53M +245% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 $1.44M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.